Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.41 AUD | -2.08% | +11.46% | +19.49% |
Apr. 16 | XRF Scientific's Profit Before Tax Rises 15% in March Quarter | MT |
Feb. 20 | XRF Scientific Shares Decline 5% Despite Higher Fiscal H1 Revenue, EPS | MT |
Sales 2024 * | 59.1M 38.29M | Sales 2025 * | 63.8M 41.34M | Capitalization | 199M 129M |
---|---|---|---|---|---|
Net income 2024 * | 8M 5.18M | Net income 2025 * | 10M 6.48M | EV / Sales 2024 * | 3.18 x |
Net cash position 2024 * | 10.9M 7.06M | Net cash position 2025 * | 15.4M 9.98M | EV / Sales 2025 * | 2.88 x |
P/E ratio 2024 * |
22.2
x | P/E ratio 2025 * |
19.7
x | Employees | 48 |
Yield 2024 * |
2.15% | Yield 2025 * |
2.43% | Free-Float | 63.69% |
1 day | -2.08% | ||
1 week | +11.46% | ||
Current month | +14.63% | ||
1 month | +16.53% | ||
3 months | +27.60% | ||
6 months | +47.64% | ||
Current year | +19.49% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | - | 08-05-31 | |
Andrew Watson
DFI | Director of Finance/CFO | - | 13-08-27 |
Members of the board | Title | Age | Since |
---|---|---|---|
Fred Grimwade
CHM | Chairman | 66 | 12-04-30 |
David Kiggins
BRD | Director/Board Member | 54 | 12-04-30 |
David Brown
BRD | Director/Board Member | 86 | 04-06-06 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-01 | 1.41 | -2.08% | 135 184 |
24-04-30 | 1.44 | -0.69% | 291,698 |
24-04-29 | 1.45 | +5.84% | 471,185 |
24-04-26 | 1.37 | +3.40% | 313,897 |
24-04-24 | 1.325 | +4.74% | 238,851 |
Delayed Quote Australian S.E., May 01, 2024 at 02:10 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+19.49% | 129M | |
+18.51% | 26.85B | |
+23.28% | 4.55B | |
+24.95% | 1.65B | |
-15.97% | 1.09B | |
+9.04% | 1.07B | |
-38.02% | 875M | |
-3.18% | 757M | |
+2.17% | 451M | |
-15.83% | 326M |
- Stock Market
- Equities
- XRF Stock